CON
Concentra Group Holdings Parent, Inc.
NYSE · USHealthcareMedical - Equipment & Services
$31.31-0.95%
Price as of Jul 20, 2026
CON growth
Concentra Group Holdings Parent, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +15.5%
- EBITDA
- +16.2%
- EBIT
- +579.7%
- EPS
- +12.1%
- Free cash flow
- +64.0%
- Operating cash flow
- +19.4%
Forward estimates
- Revenue
- +6.7%
- EBITDA
- +99.8%
- EPS
- +13.2%
Three-year CAGR
- Revenue
- +7.9%
- EBITDA
- +7.4%
- EBIT
- +100.7%
- Net income
- +1.2%
- EPS
- +1.7%
- Free cash flow
- -4.8%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.